⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1694693 | 0.71 | — | — | |
| SCHEMBL18381791 | 0.67 | — | — | |
| SCHEMBL8910615 | 0.58 | — | — | |
| SCHEMBL21653962 | 0.57 | — | — | |
| SCHEMBL2049560 | 0.56 | — | — | |
| SCHEMBL3965556 | 0.55 | — | — | |
| SCHEMBL18758176 | 0.54 | — | — | |
| SCHEMBL4830192 | 0.54 | — | — | |
| SCHEMBL22036310 | 0.51 | — | — | |
| SCHEMBL14690248 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230144581-A1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS2 AGONISTS AND METHODS OF USE | VIGIL NEUROSCIENCE, INC. | 2023-05-11 | — | — | US | disclosed |